Lactate dehydrogenase production in hepatocytes is increased at an early stage of acute liver failure.

Although the mechanism involved in acute liver failure (ALF) has not yet been clarified, microcirculatory disturbance in the liver appears to play a pivotal role in the progression of this disease. To confirm the existence of hepatic hypoxic conditions, we evaluated the amounts of lactate dehydrogenase (LDH) in hepatocytes, since its production increases under low oxygen concentrations. Histological examination was performed in 7 patients with ALF. All 7 patients underwent a liver biopsy during the acute phase of ALF, and 4 of them underwent a second biopsy during the recovery phase. The obtained samples were immunohistochemically stained with anti-LDH5 and anti-CD-68 antibodies. As controls, we examined samples from patients with acute hepatitis, chronic hepatitis and liver cirrhosis. The production of LDH by hepatocytes and the number of CD-68 positive macrophages were markedly increased at the acute phase of ALF, and both of these effects abruptly decreased during the recovery phase. By contrast, most of the samples from the patients with chronic hepatitis and acute hepatitis showed slightly any increase in LDH staining. In cirrhotic patients, partially elevated LDH production was observed mainly around the central vein, but the staining intensity was less compared to that in ALF patients. Our findings indicate that hepatic hypoxic conditions exist in ALF at the acute phase and seem to closely correlate with macrophage overactivation in the liver. We speculate that microcirculatory disturbance may be a key process in the development and progression of ALF.

[1]  L. DeLeve Hepatic microvasculature in liver injury. , 2007, Seminars in liver disease.

[2]  William M. Lee,et al.  Soluble CD163 from activated macrophages predicts mortality in acute liver failure. , 2007, Journal of hepatology.

[3]  M. Chaparro,et al.  Mechanisms of angiogenesis in chronic inflammatory liver disease. , 2007, Annals of hepatology.

[4]  S. Tsoi,et al.  Hypoxia and lactate production in trophoblast cells. , 2007, Placenta.

[5]  B. S. Sørensen,et al.  Hypoxia induced expression of endogenous markers in vitro is highly influenced by pH. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  Liu Shi,et al.  Hypoxia inducible factor-1alpha mediates protective effects of ischemic preconditioning on ECV-304 endothelial cells. , 2007, World journal of gastroenterology.

[7]  F. Chisari,et al.  Immunobiology and pathogenesis of viral hepatitis. , 2006, Annual review of pathology.

[8]  A. Shakil,et al.  Fulminant hepatic failure , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[9]  T. Hirose,et al.  Plasma osteopontin levels in patients with fulminant hepatitis. , 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

[10]  A. Blei,et al.  Etiology and management of fulminant hepatic failure , 2003, Current gastroenterology reports.

[11]  K. Okita,et al.  Ultrastructural Study of Development of Hepatic Necrosis Induced by TNF-α and D-Galactosamine , 1998, Digestive Diseases and Sciences.

[12]  Cassidy Wm,et al.  Serum lactic dehydrogenase in the differential diagnosis of acute hepatocellular injury. , 1994 .

[13]  B. Ebert,et al.  Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3' enhancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  K. Fujiwara,et al.  Hepatic sinusoidal cell destruction in the development of intravascular coagulation in acute liver failure of rats , 1989, The Journal of pathology.

[15]  K. Fujiwara,et al.  Intravascular coagulation in acute liver failure in rats and its treatment with antithrombin III. , 1988, Gut.

[16]  Z. Chmielnicki [Mechanisms of liver damage during general anesthesia]. , 1984, Polski tygodnik lekarski.

[17]  N. Horiike,et al.  Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure , 2004, Journal of Gastroenterology.

[18]  K. Okita,et al.  Ultrastructural study of development of hepatic necrosis induced by TNF-alpha and D-galactosamine. , 1998, Digestive diseases and sciences.

[19]  N. Mcintyre,et al.  Biochemical Investigations in the Management of Liver Disease , 1992 .

[20]  M. López,et al.  Laboratory tests. , 1989, The Journal of allergy and clinical immunology.